Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Top tierWe are a global leader in digital health and cloud-connected medical devices. We design innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. Our comprehensive residential care software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice.
In the company’s own words · 10-K filed Aug 8, 2025 · SEC EDGAR
Business segments
Q1 2026 · $1.43BThe company’s own SEC segment disclosure.
- Sleep And Breathing Health$1.26B88%
- Residential Care Software$170.9M12%
ResMed (RMD) reported revenue of $1.43B in Q3 2026 (quarter ended March 31, 2026), up 11% from the same quarter a year earlier. That came with a gross margin of 62% and net income of $399M (28% of revenue). For the full year FY2025, revenue was $5.15B (+9.8% year on year) and net income $1.40B. Its largest product in 2026-Q1 was Sleep And Breathing Health at $1.26B, 88% of the disclosed total, just ahead of Residential Care Software at 12%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #3 of 27 by Smart Score